Gene: MAMSTR
Official Full Name: MEF2 activating motif and SAP domain containing transcriptional regulatorprovided by HGNC
Gene Summary: Predicted to enable transcription coregulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of myotube differentiation and positive regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16362 | MAMSTR Knockout cell line (HCT 116) | Human | MAMSTR | 1:2~1:4 | Negative | Online Inquiry |
KO16363 | MAMSTR Knockout cell line (HEK293) | Human | MAMSTR | 1:3~1:6 | Negative | Online Inquiry |
KO16364 | MAMSTR Knockout cell line (A549) | Human | MAMSTR | 1:3~1:4 | Negative | Online Inquiry |
MAMSTR Gene Knockout Cell Lines are specifically engineered cellular models derived from mammalian systems that have undergone targeted gene knockout using advanced CRISPR/Cas9 technology. These cell lines serve a crucial role in molecular biology, providing a highly effective platform to study gene function, cellular pathways, and the phenotypic implications of specific gene deletions.
The key function of MAMSTR Gene Knockout Cell Lines lies in their ability to facilitate the elucidation of gene roles in various biological processes. By disrupting target genes, researchers can analyze downstream effects on cellular behavior, including proliferation, differentiation, and response to external stimuli. This knockout methodology enhances the understanding of gene interactions and molecular mechanisms by providing clear visual and functional distinctions between wild-type and modified cells.
Scientifically, these cell lines are invaluable in both research and clinical settings. They are employed extensively in drug discovery, where understanding the molecular basis of disease is critical. MAMSTR Gene Knockout Cell Lines also support the development of gene therapies and personalized medicine, allowing for tailored approaches based on specific genetic profiles of diseases.
Compared to traditional knockout methods, which often rely on time-consuming and less precise strategies, MAMSTR Gene Knockout Cell Lines offer several advantages. They are produced with high specificity and efficiency and come with comprehensive documentation, ensuring reproducibility in experiments and reducing variability. Additionally, these cell lines are validated for performance, providing users with confidence in their experimental outcomes.
For researchers and clinicians seeking reliable gene manipulation tools, MAMSTR Gene Knockout Cell Lines represent a potent solution that enhances experimental design and accelerates scientific discovery. With their ability to deliver dependable results and rigorous validation, they are an essential resource for advancing genetic research and therapeutic development.
At our company, we pride ourselves on expertise in the field of genetic engineering and cellular biology, continually delivering innovative biological products that empower researchers and clinicians to push the boundaries of scientific exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.